Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Chronic Bacterial Prostatitis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients affected by chronic bacterial prostatitis~* positivity to the Meares-Stamey test~* symptoms duration \> 3 months (dysuria, pelvic pain and/or discomfort)~Exclusion Criteria:~* positivity to Chlamydia trachomatis, Ureaplasma urealiticum, Mycoplasma, Neisseria gonorrhoeae, herpes simplex viruses (HSV 1/2) and human papillomavirus (HPV)~* age less than 18 years~* history of neurological disease, urinary stones or cancer~* allergy to fluoroquinolones~* refusal to sign the informed consent~* incomplete follow-up time.

- Gender: MALE
- Minimum Age: 19 Years
- Maximum Age: 54 Years
- Healthy Volunteers: f

Study Arms:
- Group A, antibiotics (Type: ACTIVE_COMPARATOR): Prulifloxacin 600 mg
- Group B, antibiotics plus nutraceuticals (Type: ACTIVE_COMPARATOR): Prulifoxacin plus Serenoa repens 320 mg, Lactobacillus Sporogens 200 mg, Arbutin 100 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).